Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:J7Z
Stock Latest News
Pre-Earnings
JAZZ Earnings this Week: How Will it Perform?
2d ago
JAZZ
Premium
The Fly
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
24d ago
ALXO
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $220 from $205 at TD Cowen
25d ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
1M ago
JAZZ
Premium
The Fly
BofA ups Jazz Pharmaceuticals price target, says selloff ‘unwarranted’
2M ago
JAZZ
Premium
The Fly
Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
2M ago
GM
MGM
Premium
The Fly
Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
2M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $225 from $205 at Morgan Stanley
2M ago
JAZZ
Premium
Ratings
Buy Rating on Jazz Pharmaceuticals Driven by Zanidatamab’s Differentiated Efficacy and Clear Regulatory Path in First-Line HER2+ GEA
2M ago
JAZZ
Premium
The Fly
BeOne Medicines says HERIZON-GEA-01 met dual primary endpoint of PFS
2M ago
ONC
JAZZ
Premium
The Fly
Zymeworks touts ‘unprecedented’ results from HERIZON-GEA-01 trial
2M ago
ONC
JAZZ
Premium
The Fly
Jazz reports efficacy, safety results from Phase 3 HERIZON-GEA-01 trial
2M ago
ONC
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $219 from $147 at Piper Sandler
3M ago
JAZZ
Premium
The Fly
Booking, Carvana upgraded: Wall Street’s top analyst calls
3M ago
H
MS
Premium
The Fly
Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS
3M ago
JAZZ
Premium
Ratings
Hold Rating for Jazz Pharmaceuticals Amid Balanced Risk-Reward and Competitive Challenges
3M ago
JAZZ
Premium
The Fly
Zymeworks price target raised to $40 from $30 at Stifel
3M ago
JAZZ
ZYME
Premium
Ratings
Strong Buy Rating for Jazz Pharmaceuticals Driven by Promising Ziihera Drug and Positive Market Outlook
3M ago
JAZZ
Premium
The Fly
Truist ups Jazz Pharmaceuticals price target, says Ziihera is pipeline-in-a drug
3M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $209 from $160 at Baird
3M ago
JAZZ
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
